Comparison
NAD+ vs Epitalon
Two longevity compounds with very different problems: one has a delivery problem, the other has a replication problem.
Both are sold on ageing, and both have a specific weakness that is rarely stated alongside the pitch.
NAD+ has coherent biology. Cellular NAD+ genuinely declines with age, and the enzymes that depend on it genuinely matter. Its problem is delivery: NAD+ is large and charged and does not readily enter cells. That is why serious research uses precursors instead of the molecule itself.
Epitalon has the opposite shape. Its claimed mechanism would be significant if established, and there is a body of human work behind it, from essentially one research group, in one country, with no independent replication. Its problem is not plausibility but corroboration.
| Attribute | NAD+ | Epitalon |
|---|---|---|
| What it is | A coenzyme the body already makes, not a peptide | A synthetic four-amino-acid peptide |
| Claimed mechanism | Restores declining cellular NAD+ | Activates telomerase, extending chromosome caps |
| Central weakness | Poor cellular uptake by the routes people use | No independent replication of the central findings |
| Evidence level | Early human. The decline is documented; the intervention is not | Preclinical, plus unreplicated human work from one group |
| Typical use | 50–100 mg subcutaneous, or clinic infusions over hours | 5–10 mg daily in courses of 10–20 days |
| Most reported effect | Severe injection site stinging | Drowsiness or vivid dreams |
| The cancer question | Caution. NAD+ feeds DNA repair enzymes, and that cuts both ways | Avoid. Telomerase is what lets cancer cells divide indefinitely |
Things worth knowing
- Epitalon's headline benefit and its headline risk are the same mechanism pointed in two directions. That tension is inherent to the claim rather than incidental to it.
- Most NAD+ research that gets cited concerns oral precursors, not injected NAD+. If you are injecting it, the studies quoted in support are studies of something else.
- Neither produces anything you could notice week to week. Telomere length and cellular NAD+ are not things you feel, which makes self-assessment close to meaningless here.
- Both are cheap to synthesise and widely counterfeited, so what is actually in a given vial is an open question even by this category's standards.
- NAD+ infusions are long, expensive and physically noticeable. Close to ideal conditions for a placebo response, and worth holding in mind when reading testimonials.
Full profile
NAD+
A coenzyme present in every cell, given by injection or infusion in the hope of raising cellular levels. Not a peptide, and poorly absorbed by the routes people use.
Full profile
Epitalon
A four-amino-acid peptide studied almost exclusively by one Russian research group, best known for claims about telomerase activation.
Related
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice.